ArticleJournal of the Endocrine Society2026

Real-world outcomes in patients with tumor-induced osteomalacia treated vs not treated with burosumab.

María Belén Zanchetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.